BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
US Department of Justice
Johnson and Johnson

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,169,849

« Back to Dashboard

Summary for Patent: 5,169,849

Title: Nasal pharmaceutical compositions
Abstract:A nasal pharmaceutical composition incorporates a non-toxic agent which is capable of increasing the ciliary function e.g. caffeine and at least partially antagonizing the ciliary function depressant effect of the active agent e.g. dihydroergotamine or any other constituent present in the composition.
Inventor(s): Kiechel; Jean-Rene (Rueil-Malmaison, FR), Acezat-Mispelter; Francoise (Elancourt, FR), Plas; Danielle (Rueil-Malmaison, FR)
Assignee: Sandoz Ltd. (Basel, CH)
Application Number:07/603,990
Patent Claim Types:
see list of patent claims
Composition; Compound; Formulation; Dosage form; Delivery; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,169,849

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8202781Feb 01, 1982

International Patent Family for Patent: 5,169,849

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria385656► Subscribe
AustriaA30383► Subscribe
Australia1085083► Subscribe
Australia565613► Subscribe
Belgium895750► Subscribe
Canada1197783► Subscribe
Switzerland653555► Subscribe
Cyprus1490► Subscribe
Germany3302949► Subscribe
Denmark164771► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Boehringer Ingelheim
Cantor Fitzgerald
Chinese Patent Office
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: